HealthStudy Records Complications in 86 of 2,351 Rib-Remodeling CasesBy Naomi CalderOct 29, 2026, 3:39 PM UTC
HealthNFL Pledges $500,000 to Study ALS Risk in Athletes and VeteransBy Naomi CalderOct 21, 2026, 4:47 AM UTC
HealthFace-Photo AI Model Sorts Cancer Patients by Survival Risk in StudyBy Naomi CalderOct 20, 2026, 6:32 AM UTC
BusinessSecond Shipment of Dried Cannabis Materials Shipped to Pharmacy Australia Centre of Excellence by PreveCeutical’s Canadian Licensed Producer Partner for Novel Nose-to-Brain Drug Delivery ResearchBy Nasdaq OMXMay 3, 2018, 1:30 PM UTC
BusinessNetworkNewsAudio Covers Lexaria’s Biotech Breakthrough in Nicotine DeliveryBy Nasdaq OMXApr 20, 2018, 10:00 AM UTC
BusinessCannabisNewsWire Announces Publication on Innovative Technology and Advances in Cannabis BiotechBy Nasdaq OMXApr 4, 2018, 12:30 PM UTC
BusinessPreveCeutical Announces Incorporation of Australian Subsidiary to Support Ongoing Research ProgramsBy Nasdaq OMXMar 16, 2018, 1:00 PM UTC
BusinessAurora Cannabis Exports Dried Cannabis Flower and Oils to Australia for Novel Nose-to-Brain Drug Delivery Research by PreveCeuticalBy Nasdaq OMXMar 13, 2018, 12:01 PM UTC
